Wealthspire Advisors (Maryland)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Hold	0	–	–	–	2138
2019 Q1	–	Hold	0	–	–	–	2610
2018 Q4	–	Hold	0	–	–	–	2592
2018 Q3	–	Hold	0	–	–	–	2538
2018 Q2	–	Hold	0	–	–	–	2610
2018 Q1	–	Hold	0	–	–	–	2667
2017 Q4	–	Hold	0	–	–	–	2578
2017 Q3	–	Hold	0	–	–	–	2495
2017 Q2	–	Hold	0	–	–	–	2295
2017 Q1	–	Hold	0	–	–	–	2034
2016 Q4	–	Hold	0	–	–	–	1858
2016 Q3	–	Hold	0	–	–	–	1814
2016 Q2	–	Hold	0	–	–	–	1822
2016 Q1	–	Hold	0	–	–	–	1861
2015 Q4	–	Hold	0	–	–	–	1782

Other funds holding VIRX

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Balyasny Asset Management

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Point72 Asset Management

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return